Literature DB >> 23275099

Liver steatosis in Polish children assessed by medicolegal autopsies.

Marta Rorat1, Tomasz Jurek, Ernest Kuchar, Leszek Szenborn, Wojciech Golema, Agnieszka Halon.   

Abstract

BACKGROUND: Cases of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are increasing in the pediatric population. Their growing prevalence coincides with the obesity epidemic. Assessment of the incidence requires liver biopsies on a representative population sample, which are hampered by the absence of indications for invasive examination on children without clinical symptoms. The aim of the current study was to assess the incidence of liver steatosis in the population of children up to 18 years old from Lower Silesia.
METHODS: We retrospectively reviewed 342 medico-legal autopsy reports from 2000 to 2009. We separated a group of 256 children whose death was caused by trauma. Liver steatosis was diagnosed according to the results of histopathological examinations and typical macroscopic imaging.
RESULTS: In the 265 children who died from trauma, liver steatosis was reported in 11 (4.2%) children (6 boys) aged between 6 months and 18 years old. Six of the 11 children (54.5%) were found to be overweight. In all 342 children, steatosis was found in 18 (5.3%) children (13 boys), while NASH was diagnosed in 1 (0.3%). Excess body weight was observed in 55.6% (10/18) of children with steatosis.
CONCLUSIONS: Liver steatosis can occur at any age, even in infancy. Being overweight is a very important risk factor. Gross examination of the liver is insufficient for the diagnosis of steatosis because of its lower sensitivity and specificity. Verification of liver steatosis requires reference histopathological examination.

Entities:  

Mesh:

Year:  2012        PMID: 23275099     DOI: 10.1007/s12519-012-0387-8

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  25 in total

1.  Histopathology of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J Schork; Joel E Lavine
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

2.  Do you see what I see? The role of quality histopathology in scientific study.

Authors:  Elizabeth M Brunt
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

3.  Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.

Authors:  Giorgio Radetti; Wolfgang Kleon; Joseph Stuefer; Klaus Pittschieler
Journal:  Acta Paediatr       Date:  2006-07       Impact factor: 2.299

4.  Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test.

Authors:  G Guzzaloni; G Grugni; A Minocci; D Moro; F Morabito
Journal:  Int J Obes Relat Metab Disord       Date:  2000-06

5.  Identifying risk for obesity in early childhood.

Authors:  Philip R Nader; Marion O'Brien; Renate Houts; Robert Bradley; Jay Belsky; Robert Crosnoe; Sarah Friedman; Zuguo Mei; Elizabeth J Susman
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

6.  A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.

Authors:  Nicola Santoro; Romy Kursawe; Ebe D'Adamo; Daniel J Dykas; Clarence K Zhang; Allen E Bale; Anna M Calí; Deepak Narayan; Melissa M Shaw; Bridget Pierpont; Mary Savoye; Derek Lartaud; Samuel Eldrich; Samuel W Cushman; Hongyu Zhao; Gerald I Shulman; Sonia Caprio
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

7.  Idiopathic steatohepatitis in childhood: a multicenter retrospective study.

Authors:  A D Baldridge; A R Perez-Atayde; F Graeme-Cook; L Higgins; J E Lavine
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

Review 8.  Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.

Authors:  David Preiss; Naveed Sattar
Journal:  Clin Sci (Lond)       Date:  2008-09       Impact factor: 6.124

9.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

10.  Prevalence of high body mass index in US children and adolescents, 2007-2008.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Molly M Lamb; Katherine M Flegal
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

View more
  5 in total

Review 1.  Caring for children with NAFLD and navigating their care into adulthood.

Authors:  Ali A Mencin; Rohit Loomba; Joel E Lavine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

2.  Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON).

Authors:  Rohit Kohli; Shikha Sunduram; Marialena Mouzaki; Sabina Ali; Pushpa Sathya; Stephanie Abrams; Stavra A Xanthakos; Miriam Vos; Jeffrey B Schwimmer
Journal:  J Pediatr       Date:  2016-01-01       Impact factor: 4.406

Review 3.  Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?

Authors:  Gábor Firneisz
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis.

Authors:  Evangelos Cholongitas; Ioanna Pavlopoulou; Margarita Papatheodoridi; George E Markakis; Emmanouil Bouras; Anna-Bettina Haidich; George Papatheodoridis
Journal:  Ann Gastroenterol       Date:  2021-02-26

Review 5.  MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.

Authors:  Manuele Gori; Mario Arciello; Clara Balsano
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.